Conmed/CNMD

$79.51

-1.21%
-
1D1W1MYTD1YMAX

About Conmed

CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Ticker

CNMD

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Curt Hartman

Employees

4,100

Headquarters

Largo, United States

Conmed Metrics

BasicAdvanced
$2.46B
Market cap
39.23
P/E ratio
$2.04
EPS
1.34
Beta
$0.80
Dividend rate
1%
Dividend yield

What the Analysts think about Conmed

Analyst Ratings

Majority rating from 8 analysts.
Buy

Price Targets

Average projection from 7 analysts.
39.06% upside
High $132.00
Low $98.00
$79.51
Current price
$110.57
Average price target

Conmed Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
10.09% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$327M
7.39%
Net income
$33M
108.86%
Profit margin
10.09%
94.79%

Conmed Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 4.5%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.66
$0.83
$0.90
$1.06
-
Expected
$0.60
$0.79
$0.83
$1.11
$0.74
Surprise
10.34%
4.49%
8.43%
-4.5%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Conmed stock

Buy or sell Conmed stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing